Example: Heart Attack

Search clinical trials for: Catabasis Pharmaceuticals

Total 13 results





    • NCT03917719
      Enrolling by invitation
      An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
      Conditions: Duchenne Muscular Dystrophy
    • NCT03703882
      Active, not recruiting
      Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
      Conditions: Muscular Dystrophy, Duchenne
    • NCT03680365
      Completed
      Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
      Conditions: Duchenne Muscular Dystrophy; Burden, Dependency; Disability Physical; Disease Management; Impairment; Rare Diseases
    • NCT02608697
      Completed
      A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia
      Conditions: Hypercholesterolemia
    • NCT02439216
      Completed
      Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy
      Conditions: Muscular Dystrophy, Duchenne
    • NCT02374047
      Completed
      A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects
      Conditions: Hypercholesterolemia
    • NCT02098278
      Completed
      Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia
      Conditions: Lipoprotein Lipase Deficiency, Familial; Hyperlipoproteinemia Type I; Chylomicronemia, Familial; Hypertriglyceridemia
    • NCT01968720
      Completed
      Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
      Conditions: Hyperlipidemias; Hypertriglyceridemia; Dyslipidemias; Lipid Metabolism Disorders; Metabolic Diseases
    • NCT01912560
      Completed
      Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia
      Conditions: Dyslipidemia; Hypercholesterolemia; Hypertriglyceridemia
    • NCT01725594
      Completed
      A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003
      Conditions: Dyslipidemia
    • NCT01670773
      Completed
      A Study of CAT-1004 Biomarkers in Healthy Subjects
      Conditions: Assessment of Mechanistic Blood Biomarkers in Healthy Humans
    • NCT01511900
      Completed
      A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes
      Conditions: Type 2 Diabetes
    • NCT01440166
      Completed
      Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers
      Conditions: Healthy

      Recent CRA jobs

      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations